SCHEMBL22677374

SCHEMBL22677374

C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(C=O)cc3)c3c(N)ncnn3c2CO)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 6/20 0.44
▸ KIT P10721 5/20 0.44
▸ FGFR1 P11362 3/20 0.44
▸ FGFR3 P22607 2/20 0.44
▸ FLT3 P36888 2/20 0.44
▸ NTRK1 P04629 2/20 0.44
▸ AURKA O14965 2/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ PAK4 O96013 1/20 0.44
▸ CHEK2 O96017 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ INSR P06213 1/20 0.44
▸ LCK P06239 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ CSF1R P07333 1/20 0.44
▸ LYN P07948 1/20 0.44
▸ IGF1R P08069 1/20 0.44
▸ MET P08581 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22676848 0.83 PLK4 (0.41) KDRKITFGFR1FGFR3FLT3
SCHEMBL22676814 0.82 FGFR1 (0.40) KDRKITFGFR1FGFR3FLT3
SCHEMBL30303770 0.80 KDR (0.44) KDRKITFGFR1FGFR3FLT3
SCHEMBL22676017 0.80 KDR (0.44) KDRKITFGFR1FGFR3FLT3
SCHEMBL22677013 0.75 KIT (0.45) KDRKITFGFR1FGFR3FLT3
SCHEMBL22676849 0.72 KDR (0.43) KDRKITFGFR1FGFR3FLT3
SCHEMBL30303274 0.72 KDR (0.43) KDRKITFGFR1FGFR3FLT3
SCHEMBL22675820 0.72 KDR (0.44) KDRKITFGFR1FGFR3FLT3
SCHEMBL30303526 0.72 KDR (0.44) KDRKITFGFR1FGFR3FLT3
SCHEMBL26084585 0.72 KDR (0.44) KDRKITFGFR1FGFR3FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306529-A2 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
WO-2020231990-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2020-11-19 — — WO disclosed
Send feedback